BioMarin Pharmaceutical shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in BioMarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including BioMarin Pharmaceutical held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in BioMarin Pharmaceutical by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $6.9M | 98k | 70.29 |
2024-06-30 | $8.2M | 100k | 82.33 |
2023-12-31 | $439k | 4.6k | 96.42 |
2023-09-30 | $410k | 4.6k | 88.48 |
2023-06-30 | $401k | 4.6k | 86.68 |
2023-03-31 | $372k | 3.8k | 97.24 |
2022-12-31 | $395k | 3.8k | 103.49 |
2022-09-30 | $322k | 3.8k | 84.77 |
2022-06-30 | $322k | 3.9k | 82.87 |
2022-03-31 | $281k | 3.6k | 77.10 |
2021-09-30 | $280k | 3.6k | 77.18 |
2021-03-31 | $26k | 340 | 75.51 |
2019-03-31 | $21k | 242 | 86.78 |
2018-12-31 | $21k | 241 | 87.14 |
2018-09-30 | $24k | 243 | 96.97 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors